PP-098 Evaluation of the Incidence of Cardiac Arrhytmias Detected by Holter Monitoring in Patients Treated with Oral Moxifloxacin

PP-098 Evaluation of the Incidence of Cardiac Arrhytmias Detected by Holter Monitoring in Patients Treated with Oral Moxifloxacin

Objectives The effect of moxifloxacin on QT interval is reversible and dose-related; mainly provided by weakly but rapidly activated rectifying potassium channel blockade, IKr or HERG (human ether-a-go-go-related gene) potassium channels.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2015-03, Vol.115, p.S141-S141
Hauptverfasser: Çelik, Çaşıt Olgun, Yıldırır, Aylin, Okyay, Kaan, Atar, Ilyas, Özin, Mehmet Bülent, Müderrisoğlu, Ibrahim Haldun
Format: Artikel
Sprache:eng
Schlagworte:
Antibiotics
Cardiac arrhythmia
Cardiovascular
Drug therapy
Heart rate
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives The effect of moxifloxacin on QT interval is reversible and dose-related; mainly provided by weakly but rapidly activated rectifying potassium channel blockade, IKr or HERG (human ether-a-go-go-related gene) potassium channels.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2015.01.455